1. Medtech Insight
  2. >>Device Area

MeMed Secures $93M Financing To Commercialize Diagnostics Platform

 
• By Barnaby Pickering

The company will use the money to fund its US commercialization strategy and continue to develop its host response-based product pipeline.

MeMeds Key testing platform

Israel-based diagnostics manufacturer MeMed has secured $93m in private financing, it announced January 10. 

This latest financing brings the total raised by the company to over $200m. In the past, the company has also...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diagnostics

More from Device Area